Brachytherapy
Volume 6, Issue 1 , Pages 58-61 , January 2007

Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors

  • Alexandra J. Stewart

      Affiliations

    • Department of Clinical Oncology, Royal Marsden Hospital, Sutton, Surrey, United Kingdom
    • Corresponding Author InformationCorresponding author. Department of Clinical Oncology, Royal Marsden Hospital, Downs Road, Sutton, Surrey, SM2 5PT, United Kingdom. Tel.: +44-(0)-208-642-6011; fax: +44-(0)-208-661-3470.
    • ,
  • Desmond A. O'Farrell

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA
    • ,
  • Subhakar Mutyala

      Affiliations

    • Department of Radiation Oncology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY
    • ,
  • Raphael Bueno

      Affiliations

    • Department of Thoracic Surgery, Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA
    • ,
  • David J. Sugarbaker

      Affiliations

    • Department of Thoracic Surgery, Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA
    • ,
  • Robert A. Cormack

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA
    • ,
  • Phillip M. Devlin

      Affiliations

    • Department of Radiation Oncology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA

Received 26 June 2006 ,Revised 29 August 2006 ,Accepted 30 August 2006.

References 

  1. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997;79:813–829
  2. Kacar F, Meteoglu I, Sen S, et al. Primary neuroendocrine carcinoma of the mediastinum. Pathol Oncol Res. 2002;8:200–201
  3. Hilaris BS, Martini N. Interstitial brachytherapy in cancer of the lung: A 20 year experience. Int J Radiat Oncol Biol Phys. 1979;5:1951–1956
  4. Hilaris BS, Dattatreyudu N, Beattie EJ, et al. Value of perioperative brachytherapy in the management of non-oat cell carcinoma of the lung. Int J Radiat Oncol Biol Phys. 1983;9:1161–1166
  5. Armstrong JG, Fass DF, Bains M, et al. Paraspinal tumors: Techniques and results of brachytherapy. Int J Radiat Oncol Biol Phys. 1991;20:787–790
  6. Aye RW, Mate TP, Anderson HN, et al. Extending the limits of lung cancer resection. Am J Surg. 1993;165:572–576
  7. Chen A, Galloway M, Landreneau R, et al. Intraoperative 125I brachytherapy for high-risk stage I non-small cell lung carcinoma. Int J Radiat Oncol Biol Phys. 1999;44:1057–1063
  8. D'Amato TA, Galloway M, Szydlowski G, et al. Intraoperative brachytherapy following thoracoscopic wedge resection of stage I lung cancer. Chest. 1998;114:1112–1115
  9. Fleischman EH, Kagan AR, Streeter OE, et al. Iodine 125 interstitial brachytherapy in the treatment of carcinoma of the lung. J Surg Oncol. 1992;49:25–28
  10. Harms W, Becker HD, Krempien R, et al. Contemporary role of modern brachytherapy techniques in the management of malignant thoracic tumors. Semin Surg Oncol. 2001;20:57–65
  11. Rogers CL, Theodore N, Dickman CA, et al. Surgery and permanent 125I seed paraspinal brachytherapy for malignant tumors with spinal cord compression. Int J Radiat Oncol Biol Phys. 2002;54:505–513
  12. Hilaris BS, Mastoras DA. Contemporary brachytherapy approaches in non-small cell lung cancer. J Surg Oncol. 1998;69:258–264
  13. Hilaris BS, Gomez J, Nori D, et al. Combined surgery, intraoperative brachytherapy and postoperative external radiation in stage III non small cell lung cancer. Cancer. 1985;55:1226–1231
  14. Santos R, Colonias A, Parda D, et al. Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with stage I non small cell lung cancer. Surgery. 2003;134:691–697
  15. Fernando HC, Santos RS, Benfield JR, et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non small cell lung cancer. J Thorac Cardiovasc Surg. 2005;129:261–267
  16. Burt ME, Pomerantz AH, Bains MS, et al. Results of surgical treatment of stage III lung cancer invading the mediastinum. Surg Clin North Am. 1987;67:987–1000
  17. Lee W, Daly BD, DiPetrillo TA, et al. Limited resection for non small cell lung cancer: Observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 2003;5:237–242
  18. Fukuhara K, Osugi H, Tokuhara T, et al. Surgical repair of esophagobronchial fistula caused by radiation injury. Hepatogastroenterology. 2004;51:754–756
  19. Hama Y, Uematsu M, Shioda A, et al. Severe complications after hypofractionated high dose rate intracavitary brachytherapy following external beam irradiation for oesophageal carcinoma. Br J Radiol. 2002;5:238–242
  20. Kuliszkiewicz-Janus M, Mazur G, Gabrys K, et al. Tracheo and broncho-esophageal fistulas in Hodgkin's disease. Acta Haematol Pol. 1993;24:71–75
  21. Gaspar LE, Nag S, Herskovic A, et al. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Int J Radiat Oncol Biol Phys. 1997;38:127–132
  22. Okawa T, Dokiya T, Nishio M, et al. Multi-institutional randomized trial of radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Int J Radiat Oncol Biol Phys. 1999;45:623–628
  23. Mutyala S, Stewart AJ, Cormack RC, et al. Toxicity of permanent I-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies. Int J Radiat Oncol Biol Phys. 2005;63:S392–S693

 All research was conducted at the Brigham and Women's Hospital, Dana Farber Cancer Institute, Boston, MA.

PII: S1538-4721(06)00249-2

doi: 10.1016/j.brachy.2006.08.009

Brachytherapy
Volume 6, Issue 1 , Pages 58-61 , January 2007

Article Tools

* Image Usage & Resolution